After Admitting Mistake, AstraZeneca Faces Difficult Questions About Its Vaccine
Some trial participants only got a partial dose of AstraZeneca’s vaccine. Experts said the company’s spotty disclosures have eroded confidence.
x
After Admitting Mistake, AstraZeneca Faces Difficult Questions About Its Vaccine
Some trial participants only got a partial dose of AstraZeneca’s vaccine. Experts said the company’s spotty disclosures have eroded confidence.